comparemela.com
Latest Breaking News On - George institute for global health hiddo heerspink - Page 1 : comparemela.com
ALIGN Study: Atrasentan Shows Significant Benefit on Proteinuria in IgAN at 36 Weeks
Atrasentan significantly reduces proteinuria in patients with IgA nephropathy, showing a 36.1% reduction compared to placebo at 36 weeks.
Bonnie-schneider
Hiddo-heerspink
Igan-foundation
George-institute-for-global-health-hiddo-heerspink
Department-of-clinical-pharmacy
Novartis
European-renal-association-congress
University-medical-center-groningen
George-institute
Global-health
Clinical-trials
Personalized-medicine
vimarsana © 2020. All Rights Reserved.